Novacyt S.A. reiterates revenue guidance of £100 million for the full year 2021, excluding DHSC revenues, as announced on 22 June 2021.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.786 EUR | +10.08% | +32.71% | +9.26% |
Apr. 11 | Yourgene CEO to become head of Novacyt after acquisition | AN |
Apr. 11 | Novacyt: changes to the Board of Directors | CF |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.26% | 53.59M | |
-27.82% | 930M | |
-22.12% | 125M | |
+1.90% | 58.14M | |
-2.40% | 50.15M |
- Stock Market
- Equities
- ALNOV Stock
- News Novacyt
- Novacyt S.A. Reiterate Revenue Guidance for the Full Year 2021